Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 350 | 0 | 0 | 700 | 1,418 |
| Cost of Goods | 539 | N/A | N/A | 11,944 | 1,968 |
| Gross Profit | -189 | N/A | N/A | -11,244 | -550 |
| Operating Expenses | 77,289 | 56,257 | 43,574 | 47,757 | 63,432 |
| Operating Income | -76,939 | -56,257 | -43,574 | -58,057 | -63,014 |
| Other Income | 4,158 | 2,672 | 1,364 | -448 | -646 |
| Pre-tax Income | -72,781 | -53,585 | -42,210 | -58,505 | -63,660 |
| Net Income Continuous | -72,781 | -53,585 | -42,210 | -58,505 | -63,660 |
| Net Income | $-72,781 | $-53,585 | $-42,210 | $-58,505 | $-63,660 |
| EPS Basic Total Ops | -1.08 | -0.92 | -0.85 | -1.72 | -2.28 |
| EPS Basic Continuous Ops | -1.08 | -0.92 | -0.85 | -1.72 | -2.28 |
| EPS Diluted Total Ops | -1.08 | -0.92 | -0.85 | -1.72 | -2.28 |
| EPS Diluted Continuous Ops | -1.08 | -0.92 | -0.85 | -1.72 | -2.28 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.87 | -0.85 | -1.65 | -2.24 |
| EBITDA(a) | $-75,868 | $-55,079 | $-42,367 | $-56,702 | $-61,855 |